ОбзорГрафикНовостиTraderScreen

Morgan Stanley Call 820 LLY 20.12.../  DE000ME8T152  /

Stuttgart
12.11.2024  16:47:29 Изменение-0.51 Бид22:00:36 Предложение22:00:36 Базовый актив Цена исполнения Дата истечения Тип опциона
1.74EUR -22.67% -
Величина цены спроса: -		 -
Величина цены предложения: -		 ELI LILLY 820.00 - 20.12.2024 Call
TeleTrader 30.10 US opens lower after earnings, jobs, GDP data
TeleTrader 30.10 Eli Lilly's Q3 revenue up 20% to $11.4 billion
TeleTrader 11.10 Eli Lilly's obesity drug nears approval in Japan, CEO confirms
TeleTrader 02.10 Eli Lilly to commit $4.5 billion in a new Indiana facility
Newsfile Corp 17.09 Precision Healthcare Innovator Brian Meshkin and Leading Litigation Law Firm, Plante Huguenin Lebovi...
Newsfile Corp 16.09 Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer
Newsfile Corp 11.09 Les FNB Harvest (TSX : LLYH, LLYH.U, AMZH, AMZH.U, MSFH, MSFH.U, NVDH, NVDH.U, LLHE, LLHE.U, AMHE, A...
Newsfile Corp 11.09 Harvest ETFs (TSX: LLYH, LLYH.U, AMZH, AMZH.U, MSFH, MSFH.U, NVDH, NVDH.U, LLHE, LLHE.U, AMHE, AMHE....
Newsfile Corp 11.09 Statistiques de financement par actions du Groupe TMX pour août 2024
TeleTrader 09.09 Eli Lilly appoints Lucas Montarce as CFO
GlobeNewswire 03.09 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
Newsfile Corp 28.08 The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...
GlobeNewswire 27.08 Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership...
GlobeNewswire 26.08 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 21.08 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 21.08 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...
GlobeNewswire 19.08 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 14.08 Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s ...
GlobeNewswire 14.08 Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD...
TeleTrader 09.08 US trades up premarket after yesterday's earnings
TeleTrader 08.08 Wall Street rallies at close, Dow soars 680 pts
GlobeNewswire 08.08 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...
TeleTrader 08.08 US opens higher with data, earnings in focus
GlobeNewswire 08.08 ProQR Announces Second Quarter 2024 Operating and Financial Results
TeleTrader 08.08 Eli Lilly's Q2 revenue jumps 36% to $11.3B